Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Acute Coronary Syndrome

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Acute Coronary Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cherniatina, MA; Kharchenko, AV; Mikhin, VP; Panchenko, GV; Tsukanova, IuA1

Trials

1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Acute Coronary Syndrome

ArticleYear
[Efficiency of meldonium in the complex therapy of acute coronary syndrome].
    Kardiologiia, 2014, Volume: 54, Issue:11

    Topics: Acute Coronary Syndrome; Cardiovascular Agents; Coronary Angiography; Diastole; Drug Administration Routes; Drug Monitoring; Electrocardiography; Female; Humans; Male; Methylhydrazines; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Treatment Outcome; Ventricular Function, Left

2014